SpringWorks Therapeutics, Inc. (SWTX)
USD 46.23
(0.04%)
USD 46.23
(0.04%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -343.01 Million USD | -22.21% |
| 2022 | -280.67 Million USD | -61.8% |
| 2021 | -173.46 Million USD | -274.47% |
| 2020 | -46.32 Million USD | 21.8% |
| 2019 | -59.23 Million USD | -220.37% |
| 2018 | -18.49 Million USD | -296.8% |
| 2017 | -4.66 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -44.92 Million USD | 52.18% |
| 2024 Q1 | -93.93 Million USD | 4.6% |
| 2023 Q3 | -83.99 Million USD | -1.38% |
| 2023 Q2 | -82.85 Million USD | -6.63% |
| 2023 FY | -343.01 Million USD | -22.21% |
| 2023 Q1 | -77.69 Million USD | 0.96% |
| 2023 Q4 | -98.46 Million USD | -17.22% |
| 2022 Q4 | -78.45 Million USD | -9.36% |
| 2022 Q3 | -71.74 Million USD | -3.95% |
| 2022 Q2 | -69.01 Million USD | -12.27% |
| 2022 Q1 | -61.46 Million USD | -10.17% |
| 2022 FY | -280.67 Million USD | -61.8% |
| 2021 FY | -173.46 Million USD | -274.47% |
| 2021 Q1 | -29.75 Million USD | -365.23% |
| 2021 Q3 | -40.89 Million USD | 13.03% |
| 2021 Q4 | -55.79 Million USD | -36.44% |
| 2021 Q2 | -47.02 Million USD | -58.02% |
| 2020 FY | -46.32 Million USD | 21.8% |
| 2020 Q4 | 11.21 Million USD | 151.96% |
| 2020 Q1 | -16.13 Million USD | 7.14% |
| 2020 Q2 | -19.82 Million USD | -22.88% |
| 2020 Q3 | -21.59 Million USD | -8.93% |
| 2019 Q4 | -17.37 Million USD | -13.32% |
| 2019 FY | -59.23 Million USD | -220.37% |
| 2019 Q3 | -15.32 Million USD | -3.22% |
| 2019 Q2 | -14.85 Million USD | -27.06% |
| 2019 Q1 | -11.68 Million USD | -81.29% |
| 2018 Q1 | -3.4 Million USD | 0.0% |
| 2018 Q2 | -3.4 Million USD | 0.0% |
| 2018 Q3 | -5.23 Million USD | -53.51% |
| 2018 Q4 | -6.44 Million USD | -23.27% |
| 2018 FY | -18.49 Million USD | -296.8% |
| 2017 FY | -4.66 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Absci Corporation | -115.51 Million USD | -196.942% |
| Adaptive Biotechnologies Corporation | -227.03 Million USD | -51.084% |
| Alnylam Pharmaceuticals, Inc. | -282.17 Million USD | -21.56% |
| Alzamend Neuro, Inc. | -9.93 Million USD | -3351.653% |
| Apollomics, Inc. | -54.83 Million USD | -525.548% |
| 180 Life Sciences Corp. | -13.47 Million USD | -2445.079% |
| Atossa Therapeutics, Inc. | -31.37 Million USD | -993.199% |
| Bicycle Therapeutics plc | -189.94 Million USD | -80.584% |
| Barinthus Biotherapeutics plc | -83.91 Million USD | -308.767% |
| BioXcel Therapeutics, Inc. | -171.78 Million USD | -99.679% |
| CASI Pharmaceuticals, Inc. | -25.28 Million USD | -1256.855% |
| Chimerix, Inc. | -93.06 Million USD | -268.574% |
| CRISPR Therapeutics AG | -222.53 Million USD | -54.137% |
| Contineum Therapeutics, Inc. Class A Common Stock | 16.07 Million USD | 2233.563% |
| EyePoint Pharmaceuticals, Inc. | -73.66 Million USD | -365.658% |
| Fortress Biotech, Inc. | -142.34 Million USD | -140.978% |
| Fortress Biotech, Inc. | -142.34 Million USD | -140.978% |
| Gritstone bio, Inc. | -154.63 Million USD | -121.822% |
| Allakos Inc. | -196.05 Million USD | -74.957% |
| Boundless Bio, Inc. Common Stock | -54.79 Million USD | -525.982% |
| Cara Therapeutics, Inc. | -121.49 Million USD | -182.327% |
| Cytokinetics, Incorporated | -496.2 Million USD | 30.873% |
| enGene Holdings Inc. Common Stock | -26.06 Million USD | -1216.243% |
| Innoviva, Inc. | 176.7 Million USD | 294.112% |
| Hoth Therapeutics, Inc. | -7.69 Million USD | -4359.207% |
| NLS Pharmaceutics AG | -11.8 Million USD | -2805.151% |
| RAPT Therapeutics, Inc. | -127.06 Million USD | -169.957% |
| Salarius Pharmaceuticals, Inc. | -12.89 Thousand USD | -2659958.907% |
| Terns Pharmaceuticals, Inc. | -102.55 Million USD | -234.458% |
| Vigil Neuroscience, Inc. | -88.86 Million USD | -285.989% |
| ImmuCell Corporation | -5.74 Million USD | -5867.438% |
| IDEAYA Biosciences, Inc. | -134.42 Million USD | -155.163% |
| Incyte Corporation | 620.52 Million USD | 155.278% |
| Inovio Pharmaceuticals, Inc. | -135.22 Million USD | -153.658% |
| Lexaria Bioscience Corp. | -6.53 Million USD | -5149.646% |
| Mustang Bio, Inc. | -50.72 Million USD | -576.207% |
| MiMedx Group, Inc. | 37.11 Million USD | 1024.165% |
| MEI Pharma, Inc. | 14.54 Million USD | 2458.775% |
| MacroGenics, Inc. | -168.24 Million USD | -103.878% |
| Monopar Therapeutics Inc. | -8.83 Million USD | -3784.089% |
| Mereo BioPharma Group plc | -28.41 Million USD | -1107.112% |
| Marker Therapeutics, Inc. | -14.58 Million USD | -2252.405% |
| Marinus Pharmaceuticals, Inc. | -131.48 Million USD | -160.876% |
| Maravai LifeSciences Holdings, Inc. | -31.64 Million USD | -983.838% |
| Minerva Neurosciences, Inc. | -23.11 Million USD | -1383.647% |
| NeuroBo Pharmaceuticals, Inc. | -15.88 Million USD | -2059.216% |
| NeuroSense Therapeutics Ltd. | -12.04 Million USD | -2746.817% |
| NextCure, Inc. | -67.63 Million USD | -407.138% |
| Orchestra BioMed Holdings, Inc. | -51.5 Million USD | -565.967% |
| Ocuphire Pharma, Inc. | -10.56 Million USD | -3147.307% |
| Onconetix, Inc. | -36.03 Million USD | -851.899% |
| Oncternal Therapeutics, Inc. | -41.71 Million USD | -722.297% |
| Opthea Limited | -191.84 Million USD | -78.799% |
| Ovid Therapeutics Inc. | -59.28 Million USD | -478.618% |
| Psyence Biomedical Ltd. | -2.75 Million USD | -12364.928% |
| PDS Biotechnology Corporation | -43.04 Million USD | -696.866% |
| Precigen, Inc. | -88.92 Million USD | -285.742% |
| Pieris Pharmaceuticals, Inc. | -29.75 Million USD | -1052.752% |
| Prime Medicine, Inc. | -191.29 Million USD | -79.314% |
| PureTech Health plc | -146.19 Million USD | -134.621% |
| Rocket Pharmaceuticals, Inc. | -259.65 Million USD | -32.101% |
| Regeneron Pharmaceuticals, Inc. | 4.04 Billion USD | 108.476% |
| Replimune Group, Inc. | -234.77 Million USD | -46.104% |
| Revelation Biosciences, Inc. | -8.65 Million USD | -3862.416% |
| Rigel Pharmaceuticals, Inc. | -20.49 Million USD | -1573.969% |
| TransCode Therapeutics, Inc. | -19.41 Million USD | -1666.422% |
| Revolution Medicines, Inc. Warrant | -487.18 Million USD | 29.593% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.3 Million USD | -1311.192% |
| Sesen Bio, Inc. | -25.9 Million USD | -1223.914% |
| Sangamo Therapeutics, Inc. | -274 Million USD | -25.185% |
| Solid Biosciences Inc. | -104.31 Million USD | -228.824% |
| Syndax Pharmaceuticals, Inc. | -229.95 Million USD | -49.166% |
| SciSparc Ltd. | -5.77 Million USD | -5841.677% |
| Sutro Biopharma, Inc. | -89.27 Million USD | -284.208% |
| TG Therapeutics, Inc. | 20.63 Million USD | 1762.449% |
| Tonix Pharmaceuticals Holding Corp. | -118.38 Million USD | -189.756% |
| Titan Pharmaceuticals, Inc. | -7.27 Million USD | -4613.659% |
| Travere Therapeutics, Inc. | -376.74 Million USD | 8.953% |
| UroGen Pharma Ltd. | -65.53 Million USD | -423.396% |
| Verrica Pharmaceuticals Inc. | -65.75 Million USD | -421.621% |
| XOMA Corporation | -41.84 Million USD | -719.664% |
| Zentalis Pharmaceuticals, Inc. | -248.98 Million USD | -37.763% |
| AbCellera Biologics Inc. | -237.2 Million USD | -44.605% |
| Longboard Pharmaceuticals, Inc. | -56.75 Million USD | -504.332% |
| Cassava Sciences, Inc. | -105.95 Million USD | -223.728% |
| Corbus Pharmaceuticals Holdings, Inc. | -45.07 Million USD | -660.944% |
| Precision BioSciences, Inc. | -43.73 Million USD | -684.281% |
| Dyadic International, Inc. | -8.22 Million USD | -4067.969% |
| Intensity Therapeutics, Inc. | -8.31 Million USD | -4023.248% |
| Eton Pharmaceuticals, Inc. | -1.19 Million USD | -28676.258% |
| VYNE Therapeutics Inc. | -29.25 Million USD | -1072.373% |
| Tenaya Therapeutics, Inc. | -131.19 Million USD | -161.457% |
| IGM Biosciences, Inc. | -263.46 Million USD | -30.195% |
| X4 Pharmaceuticals, Inc. | -107.52 Million USD | -219.017% |
| Acelyrin, Inc. | -422.06 Million USD | 18.73% |
| Abeona Therapeutics Inc. | -47.13 Million USD | -627.725% |
| Ligand Pharmaceuticals Incorporated | 11.94 Million USD | 2972.325% |
| Inhibikase Therapeutics, Inc. | -20.08 Million USD | -1607.399% |
| Arcturus Therapeutics Holdings Inc. | -78.2 Million USD | -338.608% |
| Syros Pharmaceuticals, Inc. | -128.98 Million USD | -165.926% |
| Senti Biosciences, Inc. | -92.72 Million USD | -269.917% |
| Mesoblast Limited | -58.79 Million USD | -483.415% |
| Kymera Therapeutics, Inc. | -165.53 Million USD | -107.221% |
| ChromaDex Corporation | -5.59 Million USD | -6026.326% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -7058.832% |
| Akebia Therapeutics, Inc. | -46.25 Million USD | -641.554% |
| Dermata Therapeutics, Inc. | -8.04 Million USD | -4165.32% |
| Seer, Inc. | -103.46 Million USD | -231.532% |
| Xeris Biopharma Holdings, Inc. | -44.01 Million USD | -679.398% |
| Novavax, Inc. | -566.51 Million USD | 39.452% |
| Virpax Pharmaceuticals, Inc. | -15.68 Million USD | -2086.218% |
| Fate Therapeutics, Inc. | -190.51 Million USD | -80.049% |
| Checkpoint Therapeutics, Inc. | -52.14 Million USD | -557.768% |
| Lyell Immunopharma, Inc. | -245.49 Million USD | -39.721% |
| Celcuity Inc. | -66.23 Million USD | -417.909% |
| ContextLogic Inc. | -328 Million USD | -4.577% |
| Phathom Pharmaceuticals, Inc. | -167.31 Million USD | -105.014% |
| HOOKIPA Pharma Inc. | -97.69 Million USD | -251.11% |
| Jazz Pharmaceuticals plc | 578.58 Million USD | 159.285% |
| Amarin Corporation plc | -67.58 Million USD | -407.506% |
| AnaptysBio, Inc. | -164.41 Million USD | -108.631% |
| Aptevo Therapeutics Inc. | -28.87 Million USD | -1087.8% |
| Aptorum Group Limited | -10.52 Million USD | -3159.548% |
| Cartesian Therapeutics, Inc. | -86.41 Million USD | -296.932% |
| Arrowhead Pharmaceuticals, Inc. | -205 Million USD | -67.322% |
| Ardelyx, Inc. | -63.27 Million USD | -442.09% |
| Celularity Inc. | -192.28 Million USD | -78.386% |
| Omeros Corporation | -164.53 Million USD | -108.481% |
| Humacyte, Inc. | -100.04 Million USD | -242.852% |
| Immunocore Holdings plc | -59.64 Million USD | -475.052% |
| IO Biotech, Inc. | -91.44 Million USD | -275.111% |
| GT Biopharma, Inc. | -13.57 Million USD | -2426.613% |
| Cabaletta Bio, Inc. | -74.66 Million USD | -359.433% |
| Summit Therapeutics Inc. | -89.73 Million USD | -282.247% |
| Alaunos Therapeutics, Inc. | -34.26 Million USD | -901.001% |
| Pulmatrix, Inc. | -14.74 Million USD | -2227.09% |
| Intellia Therapeutics, Inc. | -515.29 Million USD | 33.433% |
| Evogene Ltd. | -26.39 Million USD | -1199.735% |
| CorMedix Inc. | -48.95 Million USD | -600.63% |
| BioLineRx Ltd. | -49.69 Million USD | -590.25% |
| VistaGen Therapeutics, Inc. | -33.02 Million USD | -938.772% |
| Sagimet Biosciences Inc. | -30.74 Million USD | -1015.852% |
| PTC Therapeutics, Inc. | -349.4 Million USD | 1.829% |
| scPharmaceuticals Inc. | -55.39 Million USD | -519.202% |
| Fulcrum Therapeutics, Inc. | -110.66 Million USD | -209.959% |
| Corcept Therapeutics Incorporated | 107.28 Million USD | 419.73% |
| NLS Pharmaceutics AG | -11.8 Million USD | -2805.151% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.3 Million USD | -1311.192% |
| Akero Therapeutics, Inc. | -172.87 Million USD | -98.423% |
| Eliem Therapeutics, Inc. | -21.46 Million USD | -1497.936% |
| Lisata Therapeutics, Inc. | -25.7 Million USD | -1234.266% |
| Stoke Therapeutics, Inc. | -114.77 Million USD | -198.862% |
| Reneo Pharmaceuticals, Inc. | -83.05 Million USD | -313.005% |
| Outlook Therapeutics, Inc. | -53.12 Million USD | -545.655% |
| ProMIS Neurosciences, Inc. | -18.89 Million USD | -1715.105% |
| Daré Bioscience, Inc. | -30.83 Million USD | -1012.238% |
| bluebird bio, Inc. | -244.26 Million USD | -40.428% |
| BioMarin Pharmaceutical Inc. | 194.44 Million USD | 276.41% |
| DBV Technologies S.A. | -76.43 Million USD | -348.782% |
| Avidity Biosciences, Inc. | -235.59 Million USD | -45.592% |
| Galecto, Inc. | -39.9 Million USD | -759.574% |
| Sensei Biotherapeutics, Inc. | -37.06 Million USD | -825.461% |
| Spruce Biosciences, Inc. | -51.99 Million USD | -559.729% |
| Inhibrx Biosciences, Inc. | -219.22 Million USD | -56.469% |
| GlycoMimetics, Inc. | -39.27 Million USD | -773.356% |
| Arcutis Biotherapeutics, Inc. | -241.1 Million USD | -42.269% |
| ADMA Biologics, Inc. | 21.63 Million USD | 1685.674% |
| Clene Inc. | -40.54 Million USD | -746.11% |
| Recursion Pharmaceuticals, Inc. | -350.06 Million USD | 2.013% |
| Aptose Biosciences Inc. | -52.35 Million USD | -555.155% |
| ZyVersa Therapeutics, Inc. | -14.42 Million USD | -2278.603% |
| Soligenix, Inc. | -7.69 Million USD | -4355.906% |
| Century Therapeutics, Inc. | -146.54 Million USD | -134.065% |
| Kura Oncology, Inc. | -165.8 Million USD | -106.879% |
| Surrozen, Inc. | -45.78 Million USD | -649.264% |
| TScan Therapeutics, Inc. | -93.45 Million USD | -267.024% |
| Ocean Biomedical, Inc. | -2.48 Million USD | -13722.035% |
| CytomX Therapeutics, Inc. | -6.48 Million USD | -5190.145% |
| Autolus Therapeutics plc | -195.02 Million USD | -75.879% |
| Mineralys Therapeutics, Inc. | -84.65 Million USD | -305.18% |
| Eterna Therapeutics Inc. | -21.13 Million USD | -1522.962% |
| Caribou Biosciences, Inc. | -116.05 Million USD | -195.551% |
| GRI Bio, Inc. | -11.38 Million USD | -2912.321% |
| Xenetic Biosciences, Inc. | -4.51 Million USD | -7495.984% |
| Janux Therapeutics, Inc. | -72.97 Million USD | -370.016% |
| INmune Bio, Inc. | -29.74 Million USD | -1053.334% |
| Heron Therapeutics, Inc. | -110.61 Million USD | -210.096% |
| SAB Biotherapeutics, Inc. | -38.07 Million USD | -800.88% |
| Pasithea Therapeutics Corp. | -15.97 Million USD | -2046.6% |
| Tenax Therapeutics, Inc. | -8.23 Million USD | -4065.842% |
| Jaguar Health, Inc. | -34.29 Million USD | -900.3% |
| Entero Therapeutics, Inc. | -15.77 Million USD | -2074.984% |
| Milestone Pharmaceuticals Inc. | -61.09 Million USD | -461.414% |
| Clearside Biomedical, Inc. | -24.84 Million USD | -1280.667% |
| Atara Biotherapeutics, Inc. | -276 Million USD | -24.277% |
| Coherus BioSciences, Inc. | -203.19 Million USD | -68.806% |
| Verastem, Inc. | -92.08 Million USD | -272.5% |
| Pliant Therapeutics, Inc. | -184.14 Million USD | -86.273% |
| Histogen Inc. | -10.64 Million USD | -3122.898% |
| Aprea Therapeutics, Inc. | -15.47 Million USD | -2116.998% |
| ACADIA Pharmaceuticals Inc. | -73.37 Million USD | -367.454% |
| Surrozen, Inc. | -45.78 Million USD | -649.264% |
| Organovo Holdings, Inc. | -15.08 Million USD | -2173.717% |
| Lixte Biotechnology Holdings, Inc. | -5.09 Million USD | -6638.646% |
| Cadrenal Therapeutics, Inc. Common Stock | -7.63 Million USD | -4393.909% |
| Centessa Pharmaceuticals plc | -171.28 Million USD | -100.261% |
| Hepion Pharmaceuticals, Inc. | -48.44 Million USD | -608.003% |
| BioRestorative Therapies, Inc. | -15.22 Million USD | -2153.584% |
| Kronos Bio, Inc. | -121.83 Million USD | -181.551% |
| Turnstone Biologics Corp. | -59.03 Million USD | -481.063% |
| Synaptogenix, Inc. | -8.31 Million USD | -4025.8% |
| Tiziana Life Sciences Ltd | -14.58 Million USD | -2251.659% |
| Entrada Therapeutics, Inc. | -3.16 Million USD | -10747.976% |
| Aurinia Pharmaceuticals Inc. | -91.69 Million USD | -274.097% |
| Exelixis, Inc. | 170.88 Million USD | 300.727% |
| Nurix Therapeutics, Inc. | -155.06 Million USD | -121.209% |
| Apellis Pharmaceuticals, Inc. | -517.12 Million USD | 33.669% |
| Jasper Therapeutics, Inc. | -68.86 Million USD | -398.124% |
| ESSA Pharma Inc. | -32.13 Million USD | -967.442% |
| TNF Pharmaceuticals, Inc. | -17.12 Million USD | -1903.223% |
| Avid Bioservices, Inc. | -18.67 Million USD | -1736.455% |
| Insmed Incorporated | -709.62 Million USD | 51.663% |
| MediWound Ltd. | -15.29 Million USD | -2143.381% |
| OmniAb, Inc. | -69.41 Million USD | -394.12% |
| Alector, Inc. | -151.74 Million USD | -126.053% |
| Seres Therapeutics, Inc. | -107.98 Million USD | -217.655% |
| Zai Lab Limited | -366.57 Million USD | 6.427% |
| AlloVir, Inc. | -181.33 Million USD | -89.164% |
| Revance Therapeutics, Inc. | -316.77 Million USD | -8.282% |
| ORIC Pharmaceuticals, Inc. | -110.78 Million USD | -209.634% |
| Aura Biosciences, Inc. | -84.99 Million USD | -303.587% |
| Immunic, Inc. | -99.22 Million USD | -245.699% |
| Tarsus Pharmaceuticals, Inc. | -143.15 Million USD | -139.604% |
| Veracyte, Inc. | -85.79 Million USD | -299.805% |
| InMed Pharmaceuticals Inc. | - USD | Infinity% |
| FibroGen, Inc. | -281.81 Million USD | -21.716% |
| SeaStar Medical Holding Corporation | -14.21 Million USD | -2313.885% |
| Catalyst Pharmaceuticals, Inc. | 86.81 Million USD | 495.122% |
| Adial Pharmaceuticals, Inc. | -6.88 Million USD | -4879.902% |
| Sonnet BioTherapeutics Holdings, Inc. | -18.79 Million USD | -1725.254% |
| Cyclacel Pharmaceuticals, Inc. | -25.45 Million USD | -1247.633% |
| Amylyx Pharmaceuticals, Inc. | 38.8 Million USD | 984.009% |
| Fortrea Holdings Inc. | 63.1 Million USD | 643.602% |
| KalVista Pharmaceuticals, Inc. | -140.44 Million USD | -144.233% |
| XBiotech Inc. | -37.51 Million USD | -814.457% |
| Jasper Therapeutics, Inc. | -68.86 Million USD | -398.124% |
| Keros Therapeutics, Inc. | -169.94 Million USD | -101.842% |
| SELLAS Life Sciences Group, Inc. | -37.86 Million USD | -805.788% |
| Lyra Therapeutics, Inc. | -67.12 Million USD | -411.044% |
| Foghorn Therapeutics Inc. | -107.9 Million USD | -217.881% |
| Agenus Inc. | -159.54 Million USD | -114.989% |
| Y-mAbs Therapeutics, Inc. | -25.67 Million USD | -1236.137% |
| Theravance Biopharma, Inc. | -53.29 Million USD | -543.648% |
| Ultragenyx Pharmaceutical Inc. | -569.2 Million USD | 39.739% |
| Metagenomi, Inc. Common Stock | -78.49 Million USD | -337.004% |
| BioCryst Pharmaceuticals, Inc. | -103.7 Million USD | -230.746% |
| Gain Therapeutics, Inc. | -22.25 Million USD | -1441.414% |
| C4 Therapeutics, Inc. | -139.03 Million USD | -146.717% |
| Creative Medical Technology Holdings, Inc. | -5.62 Million USD | -6003.291% |
| Chemomab Therapeutics Ltd. | -25.45 Million USD | -1247.315% |
| Lantern Pharma Inc. | -17.87 Million USD | -1818.678% |
| Eledon Pharmaceuticals, Inc. | -43 Million USD | -697.705% |
| Ainos, Inc. | -13.2 Million USD | -2497.325% |
| Pluri Inc. | -22.15 Million USD | -1448.032% |
| Prothena Corporation plc | -191.03 Million USD | -79.554% |
| Adaptimmune Therapeutics plc | -138.03 Million USD | -148.492% |
| Rallybio Corporation | -78.93 Million USD | -334.568% |
| Kodiak Sciences Inc. | -277.32 Million USD | -23.688% |
| Cue Biopharma, Inc. | -52.14 Million USD | -557.756% |
| MeiraGTx Holdings plc | -137.06 Million USD | -150.263% |
| Annexon, Inc. | -143.72 Million USD | -138.663% |
| Assembly Biosciences, Inc. | -64.64 Million USD | -430.602% |
| Moderna, Inc. | -4.23 Billion USD | 91.908% |
| Cocrystal Pharma, Inc. | -18.55 Million USD | -1748.23% |
| Cidara Therapeutics, Inc. | -24.48 Million USD | -1301.025% |
| Blueprint Medicines Corporation | -486.27 Million USD | 29.461% |
| Immix Biopharma, Inc. | -16.14 Million USD | -2025.089% |
| CalciMedica, Inc. | -21.87 Million USD | -1468.059% |
| Monte Rosa Therapeutics, Inc. | -143.31 Million USD | -139.349% |
| Scholar Rock Holding Corporation | -171.29 Million USD | -100.247% |
| Wave Life Sciences Ltd. | -67.99 Million USD | -404.461% |
| Sana Biotechnology, Inc. | -326.9 Million USD | -4.929% |
| Elicio Therapeutics, Inc. | -35.74 Million USD | -859.611% |
| Adlai Nortye Ltd. American Depositary Shares | -67.55 Million USD | -407.784% |
| Nutriband Inc. | -4.87 Million USD | -6940.604% |
| Protara Therapeutics, Inc. | -43.61 Million USD | -686.493% |
| Vor Biopharma Inc. | -126.03 Million USD | -172.155% |
| Roivant Sciences Ltd. | 4.24 Billion USD | 108.086% |
| Alkermes plc | 414.12 Million USD | 182.829% |
| ProKidney Corp. | -151.52 Million USD | -126.378% |
| Applied Therapeutics, Inc. | -64.53 Million USD | -431.515% |
| Arcellx, Inc. | -89.88 Million USD | -281.634% |
| BridgeBio Pharma, Inc. | -607.37 Million USD | 43.525% |
| Tango Therapeutics, Inc. | -114.17 Million USD | -200.433% |
| Galectin Therapeutics Inc. | -38.07 Million USD | -800.959% |
| Atai Life Sciences N.V. | -125.47 Million USD | -173.38% |
| Renovaro Biosciences Inc. | -81.63 Million USD | -320.157% |
| Aerovate Therapeutics, Inc. | -81.4 Million USD | -321.345% |
| MediciNova, Inc. | -9.9 Million USD | -3364.685% |
| Praxis Precision Medicines, Inc. | -126.37 Million USD | -171.429% |
| Cardio Diagnostics Holdings, Inc. | -7.24 Million USD | -4636.14% |
| GeoVax Labs, Inc. | -26.74 Million USD | -1182.63% |
| Axsome Therapeutics, Inc. | -231.82 Million USD | -47.962% |
| Biomea Fusion, Inc. | -126.13 Million USD | -171.941% |
| RenovoRx, Inc. | -11.39 Million USD | -2909.942% |
| Cullinan Oncology, Inc. | -191.08 Million USD | -79.504% |
| Geron Corporation | -193.94 Million USD | -76.862% |
| NRx Pharmaceuticals, Inc. | -27.58 Million USD | -1143.386% |
| 4D Molecular Therapeutics, Inc. | -112.86 Million USD | -203.909% |
| Dyne Therapeutics, Inc. | -242.16 Million USD | -41.646% |
| Kiniksa Pharmaceuticals, Ltd. | -25.19 Million USD | -1261.379% |
| Royalty Pharma plc | 1.49 Billion USD | 122.988% |
| Ventyx Biosciences, Inc. | -207.99 Million USD | -64.915% |
| Imunon, Inc. | -21.03 Million USD | -1531.032% |
| BioAtla, Inc. | -129.68 Million USD | -164.493% |
| Allogene Therapeutics, Inc. | -327.73 Million USD | -4.661% |
| Larimar Therapeutics, Inc. | -41.75 Million USD | -721.431% |
| Mersana Therapeutics, Inc. | -170.95 Million USD | -100.643% |
| Structure Therapeutics Inc. | -102.77 Million USD | -233.751% |
| 89bio, Inc. | -151.2 Million USD | -126.854% |
| Kezar Life Sciences, Inc. | -105.23 Million USD | -225.943% |
| aTyr Pharma, Inc. | -54.91 Million USD | -524.58% |
| Aligos Therapeutics, Inc. | -87.42 Million USD | -292.342% |
| Viridian Therapeutics, Inc. | -254.45 Million USD | -34.806% |
| EyeGate Pharmaceuticals, Inc. | -8.21 Million USD | -4076.589% |
| Akari Therapeutics, Plc | -16.8 Million USD | -1941.015% |
| Tevogen Bio Holdings Inc. | -8843.03 USD | -3878808.021% |
| Halozyme Therapeutics, Inc. | 337.57 Million USD | 201.611% |
| Lexicon Pharmaceuticals, Inc. | -171.75 Million USD | -99.716% |
| Liquidia Corporation | -73.38 Million USD | -367.422% |
| Entera Bio Ltd. | -8.89 Million USD | -3757.98% |
| GH Research PLC | -41.22 Million USD | -732.111% |
| Vericel Corporation | -6.46 Million USD | -5206.513% |
| Arbutus Biopharma Corporation | -78.1 Million USD | -339.18% |
| Xencor, Inc. | -138.63 Million USD | -147.415% |
| 60 Degrees Pharmaceuticals, Inc. | -5.15 Million USD | -6554.525% |
| Pasithea Therapeutics Corp. | -15.97 Million USD | -2046.6% |
| Coeptis Therapeutics Holdings, Inc. | -21.49 Million USD | -1496.069% |
| Vaxcyte, Inc. | -468.04 Million USD | 26.713% |
| Xenon Pharmaceuticals Inc. | -214.05 Million USD | -60.246% |
| Vanda Pharmaceuticals Inc. | -13.95 Million USD | -2358.522% |
| Lexaria Bioscience Corp. | -6.53 Million USD | -5149.646% |
| Portage Biotech Inc. | -18.25 Million USD | -1779.214% |
| Cardio Diagnostics Holdings, Inc. | -7.24 Million USD | -4636.14% |
| Olema Pharmaceuticals, Inc. | -104.96 Million USD | -226.8% |
| OncoCyte Corporation | -25.13 Million USD | -1264.628% |
| Qualigen Therapeutics, Inc. | -11.3 Million USD | -2934.209% |
| Processa Pharmaceuticals, Inc. | -11.45 Million USD | -2893.9% |
| Purple Biotech Ltd. | 22.27 Million USD | 1640.178% |
| Tempest Therapeutics, Inc. | -29.15 Million USD | -1076.434% |
| Sol-Gel Technologies Ltd. | -29.3 Million USD | -1070.493% |
| Rhythm Pharmaceuticals, Inc. | -184.35 Million USD | -86.059% |
| CollPlant Biotechnologies Ltd. | -7.51 Million USD | -4466.201% |
| Moleculin Biotech, Inc. | -29.63 Million USD | -1057.615% |
| United Therapeutics Corporation | 1.18 Billion USD | 128.949% |
| HilleVax, Inc. | -133.34 Million USD | -157.237% |
| Silo Pharma, Inc. | -3.85 Million USD | -8796.507% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | -8601.391% |
| Pharming Group N.V. | -4.87 Million USD | -6929.612% |
| Tharimmune, Inc. | -9.45 Million USD | -3527.763% |
| Genprex, Inc. | -31.07 Million USD | -1003.803% |
| Apogee Therapeutics, Inc. | -93 Million USD | -268.819% |
| Neumora Therapeutics, Inc. Common Stock | -188.19 Million USD | -82.266% |
| Pyxis Oncology, Inc. | -82.19 Million USD | -317.311% |
| XTL Biopharmaceuticals Ltd. | -765 Thousand USD | -44738.301% |
| Virios Therapeutics, Inc. | -5.44 Million USD | -6197.377% |
| OKYO Pharma Limited | -15.74 Thousand USD | -2177797.653% |
| Savara Inc. | -60 Million USD | -471.622% |
| Windtree Therapeutics, Inc. | -17.53 Million USD | -1855.716% |
| Curis, Inc. | -48.33 Million USD | -609.702% |
| Carmell Therapeutics Corporation | -5.21 Million USD | -6474.556% |
| Achieve Life Sciences, Inc. | -27.25 Million USD | -1158.763% |
| BeiGene, Ltd. | -1.2 Billion USD | 71.599% |
| Protagonist Therapeutics, Inc. | -93.65 Million USD | -266.263% |
| Erasca, Inc. | -141.52 Million USD | -142.369% |
| Protagenic Therapeutics, Inc. | -4.52 Million USD | -7477.092% |
| Protagenic Therapeutics, Inc. | -4.52 Million USD | -7477.092% |
| Vincerx Pharma, Inc. | -42.6 Million USD | -705.025% |
| Fresh Tracks Therapeutics, Inc. | -6.36 Million USD | -5293.286% |
| Acrivon Therapeutics, Inc. Common Stock | -67.23 Million USD | -410.155% |
| Celldex Therapeutics, Inc. | -154.54 Million USD | -121.955% |
| Cogent Biosciences, Inc. | -208.13 Million USD | -64.807% |
| Adicet Bio, Inc. | -152.03 Million USD | -125.61% |
| Amicus Therapeutics, Inc. | -73.49 Million USD | -366.722% |
| Aditxt, Inc. | -26.06 Million USD | -1216.121% |
| Adagene Inc. | -23.71 Million USD | -1346.1% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -4592.317% |
| Quantum-Si incorporated | -111.17 Million USD | -208.545% |
| Acurx Pharmaceuticals, Inc. | -14.57 Million USD | -2252.987% |
| Voyager Therapeutics, Inc. | 122.01 Million USD | 381.126% |
| Compugen Ltd. | -12.99 Million USD | -2540.186% |
| Generation Bio Co. | -138.56 Million USD | -147.55% |
| Astria Therapeutics, Inc. | -83.03 Million USD | -313.119% |
| Black Diamond Therapeutics, Inc. | -86.46 Million USD | -296.73% |
| Invivyd, Inc. | -207.78 Million USD | -65.082% |
| Relay Therapeutics, Inc. | -373 Million USD | 8.039% |
| Quoin Pharmaceuticals, Ltd. | -9.37 Million USD | -3557.438% |
| Spero Therapeutics, Inc. | 21.48 Million USD | 1696.82% |
| Artelo Biosciences, Inc. | -10.28 Million USD | -3234.432% |
| 2seventy bio, Inc. | -216.7 Million USD | -58.287% |
| Instil Bio, Inc. | -159.16 Million USD | -115.502% |
| Capricor Therapeutics, Inc. | -24.07 Million USD | -1324.599% |
| Elevai Labs, Inc. Common Stock | -3.66 Million USD | -9248.767% |
| GeoVax Labs, Inc. | -26.74 Million USD | -1182.63% |
| Citius Pharmaceuticals, Inc. | -36.73 Million USD | -833.826% |
| Relmada Therapeutics, Inc. | -103.7 Million USD | -230.768% |
| ALX Oncology Holdings Inc. | -170.27 Million USD | -101.443% |
| Vir Biotechnology, Inc. | -684.3 Million USD | 49.874% |
| Evaxion Biotech A/S | -22.19 Million USD | -1445.312% |
| Ocular Therapeutix, Inc. | -82.38 Million USD | -316.369% |
| Verve Therapeutics, Inc. | -223.12 Million USD | -53.732% |
| Tyra Biosciences, Inc. | -79.94 Million USD | -329.061% |
| Cingulate Inc. | -22.75 Million USD | -1407.141% |
| Galmed Pharmaceuticals Ltd. | 7.49 Million USD | 4678.39% |
| Unity Biotechnology, Inc. | -44.66 Million USD | -667.934% |
| Connect Biopharma Holdings Limited | -62.07 Million USD | -452.587% |
| Clearmind Medicine Inc. | -8.74 Million USD | -3824.028% |
| Bolt Biotherapeutics, Inc. | -76.19 Million USD | -350.172% |
| CERo Therapeutics Holdings, Inc. | -2.93 Million USD | -11595.014% |
| Viking Therapeutics, Inc. | -100.82 Million USD | -240.2% |
| Madrigal Pharmaceuticals, Inc. | -380.49 Million USD | 9.851% |
| ImmunityBio, Inc. | -362.25 Million USD | 5.31% |
| Korro Bio, Inc. | -84.53 Million USD | -305.769% |
| Kineta, Inc. | -15.72 Million USD | -2081.6% |
| BioVie Inc. | -32.17 Million USD | -965.934% |
| Codexis, Inc. | -68.06 Million USD | -403.92% |
| Celularity Inc. | -192.28 Million USD | -78.386% |
| Aileron Therapeutics, Inc. | -16.27 Million USD | -2007.477% |
| Crinetics Pharmaceuticals, Inc. | -222.6 Million USD | -54.088% |
| Virax Biolabs Group Limited | -6.49 Million USD | -5179.988% |
| Cibus, Inc. | -318.88 Million USD | -7.567% |
| IN8bio, Inc. | -30.33 Million USD | -1030.675% |
| Adverum Biotechnologies, Inc. | -123.79 Million USD | -177.09% |
| Avalo Therapeutics, Inc. | -23.44 Million USD | -1363.116% |
| Ionis Pharmaceuticals, Inc. | -353.73 Million USD | 3.03% |
| Eyenovia, Inc. | -25.4 Million USD | -1250.102% |
| Puma Biotechnology, Inc. | 32.64 Million USD | 1150.898% |
| Conduit Pharmaceuticals Inc. | -5.56 Million USD | -6067.08% |
| Elevation Oncology, Inc. | -45.44 Million USD | -654.787% |
| Xilio Therapeutics, Inc. | -79.13 Million USD | -333.464% |
| Cardiff Oncology, Inc. | -45.41 Million USD | -655.336% |
| Enanta Pharmaceuticals, Inc. | -137.2 Million USD | -149.997% |
| Regulus Therapeutics Inc. | -31.1 Million USD | -1002.617% |
| Moolec Science SA | -6.65 Million USD | -5055.141% |
| Acumen Pharmaceuticals, Inc. | -61.13 Million USD | -461.047% |
| LAVA Therapeutics N.V. | -43.25 Million USD | -693.039% |
| Atea Pharmaceuticals, Inc. | -164.16 Million USD | -108.948% |
| Compass Therapeutics, Inc. | -50.36 Million USD | -581.081% |
| Greenwich LifeSciences, Inc. | -9.32 Million USD | -3577.293% |
| TFF Pharmaceuticals, Inc. | -21.89 Million USD | -1466.651% |
| Humacyte, Inc. | -100.04 Million USD | -242.852% |
| PMV Pharmaceuticals, Inc. | -80.13 Million USD | -328.06% |
| Avenue Therapeutics, Inc. | -14.54 Million USD | -2259.099% |
| Genelux Corporation | -24.16 Million USD | -1319.462% |
| Trevi Therapeutics, Inc. | -33.92 Million USD | -911.152% |
| Notable Labs, Ltd. | -14.65 Million USD | -2240.267% |
| Immunovant, Inc. | -282.7 Million USD | -21.331% |
| Quantum-Si incorporated | -111.17 Million USD | -208.545% |
| DiaMedica Therapeutics Inc. | -21.26 Million USD | -1512.889% |
| Vera Therapeutics, Inc. | -102.01 Million USD | -236.248% |
| Acasti Pharma Inc. | -11.31 Million USD | -2932.293% |
| MiNK Therapeutics, Inc. | -22.92 Million USD | -1396.494% |
| Soleno Therapeutics, Inc. | -41.38 Million USD | -728.854% |
| PepGen Inc. | -84.76 Million USD | -304.659% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | -1398.07% |
| BriaCell Therapeutics Corp. | -32.8 Million USD | -945.513% |
| Immuneering Corporation | -58.41 Million USD | -487.221% |
| Lixte Biotechnology Holdings, Inc. | -5.09 Million USD | -6638.646% |
| Belite Bio, Inc | -31.66 Million USD | -983.153% |
| XOMA Corporation | -41.84 Million USD | -719.664% |
| ARS Pharmaceuticals, Inc. | -67.52 Million USD | -408.017% |
| Bionomics Limited | -17.89 Billion USD | 98.083% |
| Alpha Tau Medical Ltd. | 35.68 Million USD | 1061.359% |
| uniQure N.V. | -282.87 Million USD | -21.261% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -4592.317% |
| Poseida Therapeutics, Inc. | -129.5 Million USD | -164.867% |
| Forte Biosciences, Inc. | -32.48 Million USD | -955.879% |
| Anebulo Pharmaceuticals, Inc. | -8.3 Million USD | -4028.332% |
| Enlivex Therapeutics Ltd. | -29.39 Million USD | -1066.909% |
| Conduit Pharmaceuticals Inc. | -5.56 Million USD | -6067.08% |
| SeaStar Medical Holding Corporation | -14.21 Million USD | -2313.885% |
| FibroBiologics, Inc. Common Stock | -8.88 Million USD | -3758.848% |
| Altimmune, Inc. | -95.92 Million USD | -257.57% |
| LENZ Therapeutics, Inc. | -73.11 Million USD | -369.174% |
| Alpha Tau Medical Ltd. | 35.68 Million USD | 1061.359% |
| Peak Bio, Inc. | -1356.23 USD | -25291554.07% |
| Zevra Therapeutics, Inc. | -49.6 Million USD | -591.503% |
| Benitec Biopharma Inc. | -22.49 Million USD | -1425.18% |
| Spyre Therapeutics, Inc. | -242.3 Million USD | -41.564% |
| NKGen Biotech, Inc. Common Stock | -29.74 Million USD | -1053.14% |
| Zura Bio Limited | -62.63 Million USD | -447.612% |
| PolyPid Ltd. | -22.86 Million USD | -1400.035% |
| NKGen Biotech, Inc. Warrants | -29.74 Million USD | -1053.14% |
| argenx SE | -425.04 Million USD | 19.3% |
| Immunome, Inc. | -109.53 Million USD | -213.168% |
| Verona Pharma plc | -67.83 Million USD | -405.688% |
| enGene Holdings Inc. Warrants | -26.06 Million USD | -1216.243% |
| Shattuck Labs, Inc. | -91.95 Million USD | -273.015% |
| CervoMed Inc. | -7.81 Million USD | -4290.344% |
| Plus Therapeutics, Inc. | -13.32 Million USD | -2474.979% |
| Dianthus Therapeutics, Inc. | -48.17 Million USD | -612.029% |
| Moolec Science SA | -6.65 Million USD | -5055.141% |
| Enveric Biosciences, Inc. | -16.44 Million USD | -1985.383% |
| Design Therapeutics, Inc. | -78.19 Million USD | -338.692% |
| Leap Therapeutics, Inc. | -87.04 Million USD | -294.082% |
| Seelos Therapeutics, Inc. | -40.49 Million USD | -746.967% |
| Achilles Therapeutics plc | -75.25 Million USD | -355.801% |
| CERo Therapeutics Holdings, Inc. | -2.93 Million USD | -11595.014% |
| CG Oncology, Inc. Common stock | -55.44 Million USD | -518.61% |
| Fractyl Health, Inc. Common Stock | -50.83 Million USD | -574.744% |
| Rani Therapeutics Holdings, Inc. | -66.09 Million USD | -418.938% |
| MoonLake Immunotherapeutics | -54.12 Million USD | -533.765% |
| Tourmaline Bio, Inc. | -45.4 Million USD | -655.385% |
| Beam Therapeutics Inc. | -176.48 Million USD | -94.358% |
| Mirum Pharmaceuticals, Inc. | -109.15 Million USD | -214.247% |
| AEON Biopharma, Inc. | -48.42 Million USD | -608.28% |
| Aadi Bioscience, Inc. | -71.93 Million USD | -376.851% |
| Enliven Therapeutics, Inc. | -83.52 Million USD | -310.651% |
| Kiora Pharmaceuticals, Inc. | -12.58 Million USD | -2625.16% |
| NeurAxis, Inc. | -6.66 Million USD | -5046.872% |
| Iovance Biotherapeutics, Inc. | -460.55 Million USD | 25.522% |
| Lumos Pharma, Inc. | -36.61 Million USD | -836.836% |
| Opiant Pharmaceuticals, Inc. | 5.15 Million USD | 6752.295% |
| Palisade Bio, Inc. | -13.07 Million USD | -2524.43% |
| Nutriband Inc. | -4.87 Million USD | -6940.604% |
| Taysha Gene Therapies, Inc. | -72.43 Million USD | -373.52% |
| Neurogene Inc. | -55.58 Million USD | -517.119% |
| Kintara Therapeutics, Inc. | -8.5 Million USD | -3934.972% |
| CARGO Therapeutics, Inc. Common Stock | -96.71 Million USD | -254.682% |
| Athira Pharma, Inc. | -125.46 Million USD | -173.391% |
| HCW Biologics Inc. | -25.71 Million USD | -1233.79% |
| XOMA Corporation | -41.84 Million USD | -719.664% |
| Nektar Therapeutics | -137.42 Million USD | -149.6% |
| Arvinas, Inc. | -401.5 Million USD | 14.567% |
| Tevogen Bio Holdings Inc. | -8843.03 USD | -3878808.021% |
| Merus N.V. | -156.54 Million USD | -119.112% |
| Omega Therapeutics, Inc. | -100.26 Million USD | -242.12% |
| Quince Therapeutics, Inc. | -34.62 Million USD | -890.794% |
| Rezolute, Inc. | -70.42 Million USD | -387.075% |
| Clene Inc. | -40.54 Million USD | -746.11% |
| Indaptus Therapeutics, Inc. | -16.37 Million USD | -1994.292% |
| BeyondSpring Inc. | -23.11 Million USD | -1384.005% |
| Synlogic, Inc. | -55.16 Million USD | -521.84% |
| Allarity Therapeutics, Inc. | -17.92 Million USD | -1813.174% |
| Phio Pharmaceuticals Corp. | -10.82 Million USD | -3069.004% |
| Peak Bio, Inc. | -1356.23 USD | -25291554.07% |
| Werewolf Therapeutics, Inc. | -40.5 Million USD | -746.883% |
| Krystal Biotech, Inc. | -109.72 Million USD | -212.606% |
| Karyopharm Therapeutics Inc. | -129.53 Million USD | -164.793% |
| Lipella Pharmaceuticals Inc. | -4.74 Million USD | -7127.484% |
| MannKind Corporation | 8.67 Million USD | 4052.673% |
| Ikena Oncology, Inc. | -75.41 Million USD | -354.822% |
| Cyclerion Therapeutics, Inc. | -9.64 Million USD | -3455.644% |
| Gyre Therapeutics, Inc. | -67.23 Million USD | -410.208% |
| Gossamer Bio, Inc. | -183.75 Million USD | -86.665% |
| CohBar, Inc. | -12.38 Million USD | -2668.847% |
| Cognition Therapeutics, Inc. | -50.72 Million USD | -576.234% |
| NRx Pharmaceuticals, Inc. | -27.58 Million USD | -1143.386% |
| Legend Biotech Corporation | -439.48 Million USD | 21.951% |
| Mural Oncology plc | -194.63 Million USD | -76.231% |
| Disc Medicine, Inc. | -91.12 Million USD | -276.42% |
| Champions Oncology, Inc. | -7.35 Million USD | -4563.037% |
| REGENXBIO Inc. | -268.12 Million USD | -27.929% |
| Ensysce Biosciences, Inc. | -10.71 Million USD | -3100.289% |
| Anavex Life Sciences Corp. | -55.75 Million USD | -515.204% |
| Cellectar Biosciences, Inc. | -38.96 Million USD | -780.409% |
| Edgewise Therapeutics, Inc. | -114.35 Million USD | -199.949% |
| Vaxart, Inc. | -83.34 Million USD | -311.548% |
| PharmaCyte Biotech, Inc. | -8.52 Million USD | -3925.97% |
| Aldeyra Therapeutics, Inc. | -42.79 Million USD | -701.543% |
| Cellectis S.A. | -106.62 Million USD | -221.697% |
| Longeveron Inc. | -21.02 Million USD | -1531.143% |
| Repare Therapeutics Inc. | -116.22 Million USD | -195.131% |
| Sarepta Therapeutics, Inc. | -267.82 Million USD | -28.074% |
| Inozyme Pharma, Inc. | -75.64 Million USD | -353.451% |
| Revolution Medicines, Inc. | -487.18 Million USD | 29.593% |
| Nymox Pharmaceutical Corporation | -6.65 Million USD | -5056.539% |
| Third Harmonic Bio, Inc. | -43.95 Million USD | -680.391% |
| ArriVent BioPharma, Inc. Common Stock | -74.59 Million USD | -359.865% |
| AN2 Therapeutics, Inc. | -69.63 Million USD | -392.587% |
| Anixa Biosciences, Inc. | -11.01 Million USD | -3015.185% |
| Vertex Pharmaceuticals Incorporated | 4.3 Billion USD | 107.963% |
| Denali Therapeutics Inc. | -196.69 Million USD | -74.385% |
| Revelation Biosciences, Inc. | -8.65 Million USD | -3862.416% |
| Veru Inc. | -93.78 Million USD | -265.755% |
| Corvus Pharmaceuticals, Inc. | -23.32 Million USD | -1370.329% |
| Cingulate Inc. | -22.75 Million USD | -1407.141% |
| Passage Bio, Inc. | -108.38 Million USD | -216.465% |
| Context Therapeutics Inc. | -25.07 Million USD | -1268.078% |
| Exicure, Inc. | -14.99 Million USD | -2187.363% |
| Day One Biopharmaceuticals, Inc. | -206.06 Million USD | -66.459% |
| Oramed Pharmaceuticals Inc. | -40.59 Million USD | -744.901% |
| Scinai Immunotherapeutics Ltd. | -9.71 Million USD | -3430.053% |
| Nuvalent, Inc. | -149.49 Million USD | -129.452% |
| ABVC BioPharma, Inc. | -8.21 Million USD | -4074.681% |
| Carisma Therapeutics, Inc. | -88.73 Million USD | -286.576% |
| Unicycive Therapeutics, Inc. | -20.77 Million USD | -1551.165% |
| OmniAb, Inc. | -69.41 Million USD | -394.12% |
| Anew Medical, Inc. | -1.3 Million USD | -26268.577% |
| Fennec Pharmaceuticals Inc. | -12.77 Million USD | -2585.874% |
| Lipocine Inc. | -17.93 Million USD | -1812.965% |
| Lexeo Therapeutics, Inc. Common Stock | -68.51 Million USD | -400.654% |
| Nautilus Biotechnology, Inc. | -76.15 Million USD | -350.432% |
| SAB Biotherapeutics, Inc. | -38.07 Million USD | -800.88% |
| G1 Therapeutics, Inc. | -39.52 Million USD | -767.794% |
| Bellerophon Therapeutics, Inc. | -22.38 Million USD | -1432.403% |
| Sage Therapeutics, Inc. | -579.84 Million USD | 40.844% |
| Ocugen, Inc. | -65.53 Million USD | -423.436% |
| Mind Medicine (MindMed) Inc. | -93.86 Million USD | -265.428% |
| Q32 Bio Inc. | -92.1 Million USD | -272.427% |
| Brainstorm Cell Therapeutics Inc. | -21.43 Million USD | -1499.949% |
| Alumis Inc. Common Stock | -158.17 Million USD | -116.858% |
| Equillium, Inc. | -14.52 Million USD | -2262.023% |
| Kyverna Therapeutics, Inc. | -62.4 Million USD | -449.647% |
| Coya Therapeutics, Inc. | -7.9 Million USD | -4240.097% |
| CNS Pharmaceuticals, Inc. | -18.86 Million USD | -1718.24% |
| Dominari Holdings Inc. | -21.79 Million USD | -1473.743% |
| Edesa Biotech, Inc. | -9.22 Million USD | -3619.202% |
| vTv Therapeutics Inc. | -25.5 Million USD | -1245.044% |
| Bio-Techne Corporation | 206.68 Million USD | 265.959% |
| Agios Pharmaceuticals, Inc. | -391.48 Million USD | 12.382% |
| Harmony Biosciences Holdings, Inc. | 192.03 Million USD | 278.625% |
| Prelude Therapeutics Incorporated | -132.27 Million USD | -159.314% |
| Candel Therapeutics, Inc. | -38.39 Million USD | -793.472% |
| iTeos Therapeutics, Inc. | -151.1 Million USD | -127.009% |
| Nkarta, Inc. | -131.65 Million USD | -160.549% |
| BioCardia, Inc. | -11.64 Million USD | -2845.835% |
| Iterum Therapeutics plc | -47.46 Million USD | -622.619% |